dr. james on update of ibrutinib for chronic lymphocytic leukemia
Published 7 years ago • 658 plays • Length 1:29Download video MP4
Download video MP3
Similar videos
-
1:20
dr. byrd provides an update on ibrutinib in cll
-
7:13
using ibrutinib in chronic lymphocytic leukemia (cll)
-
11:28
adverse events of ibrutinib in chronic lymphocytic leukemia
-
25:09
cll: long-term updates on ibrutinib and idelalisib
-
1:33
dr. zelenetz on treatment for patients with cll who fail on ibrutinib or idelalisib
-
24:09
update on venetoclax for cll
-
0:55
dr. pinilla-ibarz on ibrutinib's efficacy in treating high-risk patients with cll
-
1:22
dr. davids on updated data with ibrutinib/umbralisib in r/r cll and mcl
-
2:09
dr. sharman on the phase iii results of the genuine study in cll
-
0:51
dr. seymour on role of ibrutinib in cll
-
5:55
pharmacovigilance with ibrutinib in chronic lymphocytic leukemia
-
1:16
dr. woyach on ibrutinib and peripheral lymphocytosis in patients with chronic lymphocytic leukemia
-
4:07
management of cll progression after ibrutinib
-
1:05
dr. smith on using venetoclax versus ibrutinib in cll
-
4:22
progression on frontline ibrutinib in cll
-
1:16
dr. jones on long-term outcomes with ibrutinib in cll
-
8:26
small-molecule inhibitors: ibrutinib in chronic lymphocytic leukemia
-
0:53
dr. kambhampati on frontline ibrutinib plus obinutuzumab in cll
-
1:53
dr. kahl on frontline btk inhibitor selection in cll